Ivermectin for crusted Norwegian scabies induced by use of topical steroids

Archives of Dermatology

Volumn 134, Issue 2, 1998, Pages 143-145

  Jaramillo Ayerbe, Felipe ^a   Berrío Muñoz, Joaquín ^a  

^a UNIVERSIDAD DE CALDAS   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; KERATOLYTIC AGENT; LINDANE; STEROID;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; DRUG INDUCED DISEASE; EDEMA; EPIDEMIC; EPIDERMIS; FEMALE; HEADACHE; HUMAN; IMMUNE DEFICIENCY; INFESTATION; KERATODERMA; ORAL DRUG ADMINISTRATION; PARASITIC SKIN DISEASE; PRIORITY JOURNAL; PRURITUS; RASH; SCABIES; TREATMENT FAILURE; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ANTIPARASITIC AGENTS; CHILD; DERMATITIS, SEBORRHEIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INSECTICIDES; IVERMECTIN; KERATOLYTIC AGENTS; KERATOSIS; LINDANE; PSORIASIS; SCABIES;

EID: 0031909038     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.134.2.143     Document Type: Article

References (16)

1. Burns DA. Diseases caused by arthropods and other noxious animals. In: Champion RH, Burton JL, Ebling FJG, eds. Rook, Wilkinson, Ebling Textbook of Dermatology. 5th ed. Oxford, England: Blackwell Scientific Publications; 1992:1305-1307.
2. Espy PD, Jolly HW. Norwegian scabies: occurrence in a patient undergoing immunosuppression. Arch Dermatol. 1976;112:193-196.
3. Rau RC, Baird IM. Crusted scabies in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1986;15:1058-1059.
4. Clayton R, Farrow S. Norwegian scabies following topical steroid therapy. Postgrad Med J. 1975;51:599.
5. Millard LG. Norwegian scabies developing during treatment with fluorinated steroid therapy. Acta Derm Venereol. 1977;57:86-88.
6. Lipitz R, Tur E, Brenner S, Krakowski A. Norwegian scabies following topical corticosteroid therapy. Isr J Med Sci. 1981;17:1165-1168.
7. Bricklin AS, Musgnug RH. Norwegian scabies: a new complication of immunosuppressive therapy. Cutis. 1978;22:81-84.
8. Hall JC, Brewer JH, Appl BA. Norwegian scabies in a patient with acquired immune deficiency syndrome. Cutis. 1989;43:325-329.
9. Clark J, Friesen DL, Williams WA. Management of an outbreak of Norwegian scabies. Am J Infect Control. 1992;20:217-220.
10. Aubin FA, Humbert P. Ivermectin for crusted (Norwegian) scabies. N Engl J Med. 1995;332:612.
11. Ottesen EA, Campbell WC. Ivermectin in human medicine. J Antimicrob Chemother. 1994;34:195-203.
12. Macotela-Ruiz E, Peña-González G. Tratamiento de la escabiasis con ivermectina por via oral. Gac Med Mex. 1993;129:201-205.
13. Meinking TL, Taplin D, Hermida JL, Pardo R, Kerdel FA. The treatment of scabies with ivermectin. N Engl J Med. 1995;333:26-30.
14. Chijioke CP, Okonkwo PO. Adverse events following mass ivermectin therapy for onchocerciasis. Trans R Soc Trop Med Hyg. 1992;86:284-286.
15. US Food and Drug Administration. Drug approvals for November 1996. Available at: htpp://www.fda.gov. Accessed August 23, 1997.
16. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet. 1997;349:1144-1145.